2-(3,4-Difluorophenoxy)-N,N-dimethylethanamine
97%
- Product Code: 71904
CAS:
1708924-47-3
| Molecular Weight: | 201.21 g./mol | Molecular Formula: | C₁₀H₁₃F₂NO |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C |
Product Description:
Used primarily in the pharmaceutical industry, this compound serves as an intermediate in the synthesis of various active pharmaceutical ingredients (APIs). It is particularly valuable in the development of drugs targeting central nervous system disorders, such as antidepressants and anxiolytics. The compound's structure allows it to interact with specific neurotransmitter receptors, making it a key component in creating molecules that modulate brain chemistry. Additionally, it is utilized in research settings to study the effects of phenoxy derivatives on biological systems, aiding in the discovery of new therapeutic agents. Its application extends to the optimization of drug candidates for improved efficacy and safety profiles.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 0.025 | 10-20 days | Ft4,157.64 |
+
-
|
| 1.000 | 10-20 days | Ft22,205.56 |
+
-
|
| 0.100 | 10-20 days | Ft5,102.55 |
+
-
|
| 0.250 | 10-20 days | Ft8,787.73 |
+
-
|
| 5.000 | 10-20 days | Ft80,128.99 |
+
-
|
2-(3,4-Difluorophenoxy)-N,N-dimethylethanamine
Used primarily in the pharmaceutical industry, this compound serves as an intermediate in the synthesis of various active pharmaceutical ingredients (APIs). It is particularly valuable in the development of drugs targeting central nervous system disorders, such as antidepressants and anxiolytics. The compound's structure allows it to interact with specific neurotransmitter receptors, making it a key component in creating molecules that modulate brain chemistry. Additionally, it is utilized in research settings to study the effects of phenoxy derivatives on biological systems, aiding in the discovery of new therapeutic agents. Its application extends to the optimization of drug candidates for improved efficacy and safety profiles.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
Ft0.00
Ft0.00
Total :